Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT04239391
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 150 participants
- Registry
-
NCT04239391
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Puerto Rico
- Registry status
- Unknown status
Technical summary
Registry record NCT04239391. Randomized; no masking; primary purpose treatment. Start 2020-09-01 (actual); primary completion 2023-08-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)
- Condition
- End Stage Renal Disease
- Intervention (Drug)
- Triferic
- Lead sponsor
- Rockwell Medical Technologies, Inc.
Record details
- Record id
cardio:ct-nct04239391- Content hash
e343c15506ef6ec76a0d6248e84d480da4a40514c0197256d7e711ffc3fa8382